中文 | English
Return
Total: 281 , 1/29
Show Home Prev Next End page: GO
Author:(Xiao-yan GUAN)

1.Cloning, subcellular localization and expression analysis of SmIAA7 gene from Salvia miltiorrhiza

Yu-ying HUANG ; Ying CHEN ; Bao-wei WANG ; Fan-yuan GUAN ; Yu-yan ZHENG ; Jing FAN ; Jin-ling WANG ; Xiu-hua HU ; Xiao-hui WANG

Acta Pharmaceutica Sinica 2025;60(2):514-525

2. Effects of HMGB1 on phenotypes, phagocytosis and ERK/JNK/P38 MAPK signaling pathway in dendritic cells

Ying-Ying CHEN ; Zhi-Xiang MOU ; Xiao-Long HU ; Yi-Yan ZHANG ; Jiao-Qing WENG ; Tian-Jun GUAN ; Ying-Ying CHEN ; Lan CHEN ; Tian-Jun GUAN ; Lan CHEN ; Pei-Yu LYU

Chinese Pharmacological Bulletin 2024;40(2):248-255

3.A quantitative study on the outcome of patients with breast cancer after autologous breast reconstruction and implant breast reconstruction based on multi-scaleon

Qiu-Ping WU ; Jiong WU ; Ke-Da YU ; A-Yong CAO ; Xiao-Yan HUANG ; Sheng CHEN ; Lei WANG ; Jia-Qin GUAN

Fudan University Journal of Medical Sciences 2024;51(1):81-88,127

4.Identification and expression analysis of cellulose synthase family genes in Aquilaria sinensis

Xin-yu MI ; Hai-ling QIU ; Fan-yuan GUAN ; Yu-yan ZHENG ; Xiao-hui WANG ; She-po SHI

Acta Pharmaceutica Sinica 2024;59(1):253-264

5.Specific DNA barcodes screening, germplasm resource identification, and genetic diversity analysis of Platycodon grandiflorum

Xin WANG ; Yue SHI ; Jin-hui MAN ; Yu-ying HUANG ; Xiao-qin ZHANG ; Ke-lu AN ; Gao-jie HE ; Zi-qi LIU ; Fan-yuan GUAN ; Yu-yan ZHENG ; Xiao-hui WANG ; Sheng-li WEI

Acta Pharmaceutica Sinica 2024;59(1):243-252

6.Analysis of risk factors for severe illness caused by coronavirus disease 2019 in Fuzhou city

Xiao-Yan ZHENG ; Yi-Mei WANG ; Chen-Ping GUAN ; Ying JIANG ; Xiao-Yang ZHANG

Medical Journal of Chinese People's Liberation Army 2024;49(3):297-301

7.Clinical trial of pidotimod combined with budesonide suspension for inhalation in the treatment of recurrent respiratory tract infections in children

Guan-Jie JIN ; Yan ZHAO ; Xiao-Yun ZHAO

The Chinese Journal of Clinical Pharmacology 2024;40(3):307-311

8.Analysis of adverse events of polatuzumab vedotin and fam-trastuzumab deruxtecan-nxki based on OpenFDA database

Mao LIN ; Guan-Min ZHANG ; Gui-Sen YIN ; Cai-Se LING ; Hong-Tao XIAO ; Yan-Hua ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(6):904-908

9.Protective effect and mechanism of Icariin on oxidative stress injury in neurons

Yu-Meng DU ; Si-Min YANG ; Xiao-Tong QIN ; Yan LI ; Rui-Jun JU ; Xiao-Ming PENG ; Xiao-Qiang YAN ; Jie GUAN ; Ling-Yue MA

The Chinese Journal of Clinical Pharmacology 2024;40(13):1869-1873

10.Research status of mechanisms of pancreatic islet beta cell injury in type 2 diabetes

Yan-Hui ZHAI ; Yong-Lin LIANG ; Dong AN ; Yuan-Yuan ZHANG ; Fei SU ; Xiao-Wen GUAN ; Xiang-Dong ZHU

The Chinese Journal of Clinical Pharmacology 2024;40(16):2442-2446

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 281 , 1/29 Show Home Prev Next End page: GO